selected publications
-
Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability.
Methodist DeBakey cardiovascular journal.
2019
Information Resource
GET IT
Times cited: 18 -
Somatic Editing of Ldlr With Adeno-Associated Viral-CRISPR Is an Efficient Tool for Atherosclerosis Research.
Arteriosclerosis, thrombosis, and vascular biology.
2018
Academic Article
GET IT
Times cited: 62 -
Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.
Journal of clinical lipidology.
2018
Information Resource
GET IT
Times cited: 37 - Structural Stability of Streptococcal Serum Opacity Factor. The protein journal. 2017 Academic Article GET IT
-
Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester.
The Journal of biological chemistry.
2017
Academic Article
GET IT
Times cited: 30 -
Somatic genome editing with CRISPR/Cas9 generates and corrects a metabolic disease.
Scientific reports.
2017
Academic Article
GET IT
Times cited: 79 -
Neo High-Density Lipoprotein Produced by the Streptococcal Serum Opacity Factor Activity against Human High-Density Lipoproteins Is Hepatically Removed via Dual Mechanisms.
Biochemistry.
2016
Academic Article
GET IT
Times cited: 2 - Acylation of lysine residues in human plasma high density lipoprotein increases stability and plasma clearance in vivo. Biochimica et biophysica acta. 2016 Academic Article GET IT
-
Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.
Methodist DeBakey cardiovascular journal.
2016
Information Resource
GET IT
Times cited: 17 -
Speciated High-Density Lipoprotein Biogenesis and Functionality.
Current atherosclerosis reports.
2016
Information Resource
GET IT
Times cited: 6 -
Direct Measurement of the Structure of Reconstituted High-Density Lipoproteins by Cryo-EM.
Biophysical journal.
2015
Academic Article
GET IT
Times cited: 13 -
Streptococcal serum opacity factor promotes cholesterol ester metabolism and bile acid secretion in vitro and in vivo.
Biochimica et biophysica acta.
2015
Academic Article
GET IT
Times cited: 5 -
Apolipoprotein AI deficiency inhibits serum opacity factor activity against plasma high density lipoprotein via a stabilization mechanism.
Biochemistry.
2015
Academic Article
GET IT
Times cited: 5 -
Alcohol: a nutrient with multiple salutary effects.
Nutrients.
2015
Information Resource
GET IT
Times cited: 9 - Setting the course for apoAII: a port in sight?. Clinical lipidology. 2013 Academic Article GET IT
-
Free cholesterol determines reassembled high-density lipoprotein phospholipid phase structure and stability.
Biochemistry.
2013
Academic Article
GET IT
Times cited: 7 -
Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients.
Medicine and science in sports and exercise.
2013
Academic Article
GET IT
Times cited: 21 -
Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome.
Journal of clinical lipidology.
2013
Academic Article
GET IT
Times cited: 20 -
Impaired lipoprotein processing in HIV patients on antiretroviral therapy: aberrant high-density lipoprotein lipids, stability, and function.
Arteriosclerosis, thrombosis, and vascular biology.
2013
Academic Article
GET IT
Times cited: 26 -
Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients.
Metabolism: clinical and experimental.
2013
Academic Article
GET IT
Times cited: 22 -
Cholesterol determines and limits rHDL formation from human plasma apolipoprotein A-II and phospholipid membranes.
Biochemistry.
2012
Academic Article
GET IT
Times cited: 9 -
Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.
Arteriosclerosis, thrombosis, and vascular biology.
2011
Academic Article
GET IT
Times cited: 22 -
Streptococcal serum opacity factor increases the rate of hepatocyte uptake of human plasma high-density lipoprotein cholesterol.
Biochemistry.
2010
Academic Article
GET IT
Times cited: 15 -
Serum opacity factor enhances HDL-mediated cholesterol efflux, esterification and anti inflammatory effects.
Lipids.
2010
Academic Article
GET IT
Times cited: 10 -
HDL superphospholipidation enhances key steps in reverse cholesterol transport.
Atherosclerosis.
2009
Academic Article
GET IT
Times cited: 33 -
Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.
Biochemistry.
2009
Academic Article
GET IT
Times cited: 18 -
Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.
Biochimica et biophysica acta.
2009
Academic Article
GET IT
Times cited: 37 -
Disruption of human plasma high-density lipoproteins by streptococcal serum opacity factor requires labile apolipoprotein A-I.
Biochemistry.
2009
Academic Article
GET IT
Times cited: 20 -
Properties of the products formed by the activity of serum opacity factor against human plasma high-density lipoproteins.
Chemistry and physics of lipids.
2008
Academic Article
GET IT
Times cited: 6 -
Serum opacity factor unmasks human plasma high-density lipoprotein instability via selective delipidation and apolipoprotein A-I desorption.
Biochemistry.
2007
Academic Article
GET IT
Times cited: 41 -
Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.
Biochemistry.
2007
Academic Article
GET IT
Times cited: 40 -
Dynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A(2).
Journal of lipid research.
2006
Academic Article
GET IT
Times cited: 50 -
N-Glycosylation is required for secretion-competent human plasma phospholipid transfer protein.
The protein journal.
2006
Academic Article
GET IT
Times cited: 4 -
Plasma factors required for human apolipoprotein A-II dimerization.
Biochemistry.
2005
Academic Article
GET IT
Times cited: 11 -
Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways.
Glycobiology.
1998
Academic Article
GET IT
Times cited: 82 -
Decreased synthesis of glycosphingolipids in cells lacking vimentin intermediate filaments.
Experimental cell research.
1998
Academic Article
GET IT
Times cited: 51 -
Pathways of glycosphingolipid biosynthesis in SW13 cells in the presence and absence of vimentin intermediate filaments.
Glycobiology.
1996
Academic Article
GET IT
Times cited: 28 -
Biosynthesis of glycosphingolipids is reduced in the absence of a vimentin intermediate filament network.
Journal of cell science.
1994
Academic Article
GET IT
Times cited: 34 -
Human milk oligosaccharides.
Acta paediatrica (Oslo, Norway : 1992).
1994
Article
GET IT
Times cited: 3 -
Variable subcellular localization of glycosphingolipids.
Glycobiology.
1993
Academic Article
GET IT
Times cited: 68 -
Biosynthesis of the blood group Pk and P1 antigens by human kidney microsomes.
Carbohydrate research.
1992
Academic Article
GET IT
Times cited: 12 -
Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells.
Cell motility and the cytoskeleton.
1992
Academic Article
GET IT
Times cited: 62 -
Subpopulations of B cells in germinal centers. III. HJ6, a monoclonal antibody, binds globoside and a subpopulation of germinal center B cells.
Journal of immunology (Baltimore, Md. : 1950).
1991
Academic Article
GET IT
Times cited: 18 -
Association of glycosphingolipids with intermediate filaments of human umbilical vein endothelial cells.
Experimental cell research.
1991
Academic Article
GET IT
Times cited: 57 -
Interferon-gamma alters expression of endothelial cell-surface glycosphingolipids.
Archives of biochemistry and biophysics.
1990
Academic Article
GET IT
Times cited: 29 -
Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.
Journal of immunology (Baltimore, Md. : 1950).
1989
Academic Article
GET IT
Times cited: 80 -
Molecular characterization of human X/Y translocations suggests their aetiology through aberrant exchange between homologous sequences on Xp and Yq.
Annals of human genetics.
1989
Academic Article
GET IT
Times cited: 24 -
Structure of a ganglioside with Cad blood group antigen activity.
Biochemistry.
1988
Academic Article
GET IT
Times cited: 13 -
Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells.
Archives of biochemistry and biophysics.
1987
Academic Article
GET IT
Times cited: 48 -
Isolation and purification of gangliosides from plasma.
Methods in enzymology.
1987
Academic Article
GET IT
Times cited: 38 -
Three methods compared for determination of pancreatic and salivary amylase activity in serum of cystic fibrosis patients.
Clinical chemistry.
1986
Academic Article
GET IT
Times cited: 4 -
Identification of a novel ganglioside on erythrocytes with blood group Cad specificity.
The Journal of biological chemistry.
1985
Academic Article
GET IT
Times cited: 27 -
A solvent partition method for microscale ganglioside purification.
Analytical biochemistry.
1985
Academic Article
GET IT
Times cited: 168 -
Modulation of the immune response by gangliosides. Inhibition of adherent monocyte accessory function in vitro.
The Journal of clinical investigation.
1984
Academic Article
GET IT
Times cited: 99 -
Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function.
Pediatric research.
1984
Academic Article
GET IT
Times cited: 24 -
Cystic fibrosis serum pancreatic amylase. Useful discriminator of exocrine function.
American journal of diseases of children (1960).
1984
Academic Article
GET IT
Times cited: 7 -
Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides.
Cancer research.
1983
Academic Article
GET IT
Times cited: 179 -
Reference intervals for amylase isoenzymes in serum and plasma of infants and children.
Clinical chemistry.
1983
Academic Article
GET IT
Times cited: 24 -
Serum amylase isoenzymes in cystic fibrosis patients. Evidence for a generalized defect in exocrine gland secretory regulation.
Pediatric research.
1980
Academic Article
GET IT
Times cited: 8 -
Amylo-1,6-glucosidase/4-alpha-glucanotransferase. Reaction of rabbit muscle debranching enzyme with an active site-directed irreversible inhibitor, 1-S-dimethylarsino-1-thio-beta-D-glucopyranoside.
The Journal of biological chemistry.
1980
Academic Article
GET IT
Times cited: 12 -
Quantitative gel-electrophoretic determination of serum amylase isoenzyme distributions.
Clinical chemistry.
1979
Academic Article
GET IT
Times cited: 14 -
Differences between cystic fibrosis and normal saliva alpha-amylase as a function of age and sex.
Pediatric research.
1978
Academic Article
GET IT
Times cited: 4 -
Direct spectrophotometric determination of alpha-amylase activity in salive, with p-nitrophenyl alpha-maltoside as substrate.
Clinical chemistry.
1977
Academic Article
GET IT
Times cited: 28 -
Amylo-1,6-glucosidase/4-alpha-glucanotransferase: use of reversible substrate model inhibitors to study the binding and active sites of rabbit muscle debranching enzyme.
Biochemistry.
1977
Academic Article
GET IT
Times cited: 43 -
Cystic fibrosis: enzymatic detection of a ciliostatic factor.
Pediatric research.
1976
Academic Article
GET IT
Times cited: 8